Gamma-cyclodextrin

Gamma-cyclodextrin
Product Description

GCD, gammadex

CYCLOLAB Ltd.

  • HU
  • 2019
    On CPHI since
  • 4
    Certificates
  • 50 - 99
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Contract Research Organisation
Excipients Manufacturer

CYCLOLAB Ltd.

  • HU
  • 2019
    On CPHI since
  • 4
    Certificates
  • 50 - 99
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Contract Research Organisation
Excipients Manufacturer

More Products from CYCLOLAB Ltd. (46)

  • Alfadex

    Product Alfadex

    acd, alfa-cyclodextrin (EP, USP/NF)
  • Alpha-cyclodextrin

    Product Alpha-cyclodextrin

    ACD, alfadex (EP, USP/NF)
  • BCD

    Product BCD

    betadex, beta-cyclodextrin (EP, USP/NF)
  • Beta-cyclodextrin

    Product Beta-cyclodextrin

    BCD, betadex (EP, USP/NF)
  • Betadex

    Product Betadex

    bcd, betadex, beta-cyclodextrin (EP, USP/NF)
  • Betadex sulfobutyl ether sodium

    Product Betadex sulfobutyl ether sodium

    SBECD, Dexolve, sulfobutyl ether beta cyclodextrin sodium salt
  • Gammadex

    Product Gammadex

    GCD, gamma-cyclodextrin
  • GCD

    Product GCD

    gamma-cyclodextrin, gammadex
  • HPGCD

    Product HPGCD

    hydroxypropyl gamma cyclodextrin 
  • SBECD

    Product SBECD

    Dexolve, sulfobutyl ether beta cyclodextrin sodium salt, betaadex sulfobutyl ether sodium salt
  • Sulfobutyl

    Product Sulfobutyl

    Dexolve, sulfobutyl-beta cyclodextrin, betadex sulfobutyl ether sodium salt

CYCLOLAB Ltd. resources (3)

  • News Company introduction – Cyclolab Cyclodextrin Research and Development Ltd

    CycloLab Cyclodextrin Research and Development Ltd. is a private SME with the focus on cyclodextrin research and development for over 30 years. We are working in the fields of pharmaceutical, cosmetic and food industry, agrochemical, environmental and analytical applications of cyclodextrins.
  • Brochure Cyclolab Dexolve Presentation

    After a precise development work CycloLab established and validated the production of pharma grade Betadex Sulfobutyl Ether Sodium formulation excipient (SBECD, DexolveTM) in 2008. This cyclodextrin is the main component of several commercial formulations worldwide acting as a solubility and stability enhancer.
    DMF documentations were filed to the FDA (DMF No. 21922)in 2008, to Health Canada (DMF No. 2009-080) in 2009 and to China CDE in 2019 (No.F20190000489), all maintained ever since. In addition, CycloLab is a registered manufacturer of the Betadex Sulfobutyl Ether Sodium in the EudraGMDP database.

    The facility is dedicated to the production of SBECD with multiple tons annual capacity (over 350 kg/batch). Our proprietary technology is extremely robust, no OOS results have been obtained after 150 manufactured batches. The production is carried out according to cGMP (OGYÉI-57792-7/2018) and ISO 9001 and the produ...
  • News Remdesivir with Dexolve: fight against COVID-19

    CycloLab, being involved in the fight, manufactures the critical excipient: sulfobutyl-ether-BCD (SBECD, Dexolve™) that enables Remdesivir to work. The unexpected and sudden outbreak along with the quick spread of the coronavirus-disease and rapid increase of the cases draw a sudden need for Dexolve.